3mg Semaglutide Tablets

₹ 320/Strip

Strength3 mg
Pack Size1 Blister Card Of 10 Tablets
UsageType 2 Diabetes
BrandRybelsus
AdministrationOral Once Daily
Prescription TypeRx Only
Manufacture ByNovo Nordisk
AvailabilityIn Stock
Rybelsus 3mg Tablet is a prescription medicine used to improve blood sugar (glucose) in adults with type 2 diabetes. It works by helping the body release insulin when needed, reducing sugar release by the liver, and slowing food digestion. Proper blood sugar control helps prevent serious diabetes complications.

Take Rybelsus 3mg Tablet first thing in the morning, at least 30 minutes before you eat, drink, or take any other medications.

Different pack szie available 

Exports To: United States Of America | Canada | Australia | United Kingdom | The Netherlands

Find products similar to 3mg Semaglutide Tablets

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromNagpur
ShippingAs per delivery location

Product Image

3mg Semaglutide Tablets image 13mg Semaglutide Tablets image 2

About the Company

GST Registration Date
Nov 2025
Legal Status of Firm
Proprietorship
Nature of Business
Service Provider and Others
Number of Employees
Upto 10 People
IndiaMART Member Since
Dec 2025
GST
27**********1ZS
Import Export Code (IEC)
*******97M
Exports to
United States Of America | Canada | Australia | United Kingdom | The Netherlands
Incepted in year 2025, we " Remedix Global” are  Wholesaler And Exporter of Pharmaceutical Injections, Veterinary Medicines, Pharmaceutical Medicine, Skin Care Medicine, Steroids And Hormones, Anticancer Medication, Diabetic And Cardiovascular Medicine, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.
For our accomplishment story, we are grateful to our continual backing and direction have been useful to us for attaining exponential development in the current market.